Bruce C. Cozadd
2009
In 2009, Bruce C. Cozadd earned a total compensation of $838.9K as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $205,300 |
|---|---|
| Option Awards | $189,260 |
| Salary | $442,729 |
| Other | $1,574 |
| Total | $838,863 |
Cozadd received $442.7K in salary, accounting for 53% of the total pay in 2009.
Cozadd also received $205.3K in non-equity incentive plan, $189.3K in option awards and $1.6K in other compensation.
Rankings
In 2009, Bruce C. Cozadd's compensation ranked 5,045th out of 9,885 executives tracked by ExecPay. In other words, Cozadd earned more than 49.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,045 out of 9,885 | 49th |
Division Manufacturing | 1,806 out of 3,690 | 51st |
Major group Chemicals And Allied Products | 370 out of 871 | 58th |
Industry group Drugs | 231 out of 643 | 64th |
Industry Pharmaceutical Preparations | 175 out of 446 | 61st |
Source: SEC filing on June 14, 2012.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2009.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019